The Oligonucleotide Therapeutics Society (OTS) is an open, nonprofit forum to foster academia and industry-based research and development of oligonucleotide therapeutics. Join us in Munich for the 15th Annual meeting and the latest developments from the various oligonucleotide-based disciplines.

Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes. 

Get your copy of the Official Journal of the OTS at the OLIGO meeting 2019!